Scientific Online Resource System

Journal of Varna Medical College

Rehabilitation Care In Chronic Renal Disease

Nikolay Nedev


Chronic kidney disease (CKD) is a progressive condition that can negatively affect the musculoskeletal system. Given the consequences, such as low muscle mass and low bone mineral density, appropriate and timely motor therapy is important for improving locomotor and renal function. Literary data and research studies indicate that motor exercise focused on rehabilitation of renal function improves aerobic capacity, musculoskeletal function, cardiovascular function, locomotion and quality of life of patients with CKD. A suitable motor regimen includes strength training and aerobic training to favor secondary CKD complications. In this regard, physiotherapists are good members of the interdisciplinary team providing medical and health care. Their competencies are suitable in the treatment of concomitant musculoskeletal dysfunctions in CKD patients.

Providing opportunities by the legislator for official prescription of physical exercise by a specialist, together with the creation and implementation of a mobility program, is a challenge for the healthcare of the Republic of Bulgaria. Greater understanding and integration in the standard plan of rehabilitation care for people with CKD is needed.

Motor therapy can be an effective clinical strategy to improve kidney function, reducing the risk of cardiovascular diseases in patients with CKD.

The purpose of this report is to summarize the impact of CKD on the state of the musculoskeletal system and to highlight the role of motor therapy in secondary damage due to this condition.


chronic kidney disease, rehabilitation care, health care

Full Text


Близнакова Д. Хранене и бъбречнокаменна болест. Практическа педиатрия 2013:3.

Близнакова Д. Хронична бъбречна недостатъчност – как можем да забавим прогресията й? Известия на Съюза на учените – Варна, 2010, Серия Медицина и Екология 15 (1), 8-11.

Манчева П., Ненова Г., Недев Н., Крайчева Е. Ролята на рехабилитацията при хронични заболявания. Журнал на Медицински колеж – Варна. т 1, бр. 1; 30-34, 2017

Avin KG, Moorthi RN. Bone is not alone: The effects of skeletal muscle dysfunction in chronic kidney disease. Curr. Osteoporos. Rep. 2015;13:173–179.

Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 1998;147:755–763.

Centers for Disease Control and Prevention (CDC) National Chronic Kidney Disease Fact Sheet: General Information and National Estimates on Chronic Kidney Disease in the United States, 2014. US Department of Health and Human Services, Centers for Disease Control and Prevention; Atlanta, GA, USA: 2014.

Denison HJ, Cooper C, Sayer AA, Robinson SM. Prevention and optimal management of sarcopenia: A review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin. Interv. Aging. 2015;10:859–869.

Ekelund U, Steene-Johannessen J, Brown WJ, Fagerland MW, Owen N, Powell KE, Bauman A, Lee I-M. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet. 2016;388:1302–1310.

Fragala MS, Dam T-TL, Barber V, Judge JO, Studenski SA, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, et al. Strength and function response to clinical interventions of older women categorized by weakness and low lean mass using classifications from the Foundation for the National Institute of Health sarcopenia project. J. Gerontol. A Biol. Sci. Med. Sci. 2015;70:202–209.

Frontera WR, Meredith CN, O’Reilly KP, Knuttgen HG, Evans WJ. Strength conditioning in older men: Skeletal muscle hypertrophy and improved function. J. Appl. Physiol. 1988;64:1038–1044.

Harris-Love MO, Adams B, Hernandez HJ, DiPietro L, Blackman MR. Disparities in the consequences of sarcopenia: Implications for African American Veterans. Front. Physiol. 2014;5:250.

Koufaki P, Kouidi E. Current best evidence recommendations on measurement and interpretation of physical function in patients with chronic kidney disease. Sports Med. 2010;40:1055–1074.

Liu W-C, Yen J-F, Lang C-L, Yan M-T, Lu K-C. Bisphophonates in CKD patients with low bone mineral density. Sci. World J. 2013;2013:837573.

Sawant A, Garland SJ, House AA, Overend TJ. Morphological, electrophysiological, and metabolic characteristics of skeletal muscle in people with end-stage renal disease: A critical review. Physiother. Can. 2011;63:355–376.

Scott D, Daly RM, Sanders KM, Ebeling PR. Fall and fracture risk in sarcopenia and dynapenia with and without obesity: The role of lifestyle interventions. Curr. Osteoporos. Rep. 2015;13:235–244.

Thornton JS, Frémont P, Khan K, Poirier P, Fowles J, Wells GD, Frankovich RJ. Physical activity prescription: A critical opportunity to address a modifiable risk factor for the prevention and management of chronic disease: A position statement by the Canadian Academy of Sport and Exercise Medicine. Br. J. Sports Med. 2016.



Font Size